Literature DB >> 29090384

A discrete choice experiment to assess cancer patients' preferences for when and how to make treatment decisions.

Anne Herrmann1, Rob Sanson-Fisher2, Alix Hall2, Laura Wall3, Nicholas Zdenkowski4, Amy Waller2.   

Abstract

PURPOSE: Cancer patients can be overwhelmed when being confronted with their diagnosis and treatment options. Such information is often provided during one consultation between the patient and treating clinician. In order to achieve optimal cancer care, there may be justification for alternative consultation styles. We assessed, in a sample of adult medical oncology patients, their preferences for (i) attending one 40-min consultation or two 20-min consultations and (ii) receiving written only or both written and online information, when making a cancer treatment decision.
METHODS: This was a cross-sectional survey using a discrete choice design of 159 adult medical oncology patients presenting for their second or subsequent outpatient consultation. Participants were presented with a set of hypothetical scenarios and asked to indicate their most and least preferred scenario. The scenarios contained a caveat explaining that there would be no difference between the available treatment options in terms of when treatment would be initiated and the impact it would have on patients' life expectancy.
RESULTS: One hundred forty-seven patients completed the DCE. Of these, 70% (n = 103) preferred being provided with written and online information rather than just written information. This preference was statistically significant (p < 0.01). Fifty-nine percent (n = 86) of patients preferred two 20-min consultations over one 40-min consultation when making a treatment decision. Significantly, more patients preferred two shorter consultations rather than one longer consultation when this was combined with written and online information (p < 0.01).
CONCLUSION: When making a cancer treatment decision, clinicians should consider offering patients written and online information, combined with two shorter consultations.

Entities:  

Keywords:  Decision making; Discrete choice; Doctor-patient-communication; Optimal care; Patient-centred care

Mesh:

Year:  2017        PMID: 29090384     DOI: 10.1007/s00520-017-3944-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  6 in total

1.  Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences.

Authors:  Alice Yu; Deborah Street; Rosalie Viney; Stephen Goodall; Alison Pearce; Philip Haywood; Marion Haas; Eva Battaglini; David Goldstein; Hannah Timmins; Susanna B Park
Journal:  Support Care Cancer       Date:  2021-04-22       Impact factor: 3.603

2.  Men's view on participation in decisions about prostate-specific antigen (PSA) screening: patient and public involvement in development of a survey.

Authors:  Søren Birkeland; Susanne S Pedersen; Anders K Haakonsson; Michael J Barry; Nina Rottmann
Journal:  BMC Med Inform Decis Mak       Date:  2020-04-06       Impact factor: 2.796

3.  A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.

Authors:  Fei Liu; Haiyao Hu; Jing Wang; Yingyao Chen; Sun Hui; Ming Hu
Journal:  Front Public Health       Date:  2021-03-26

4.  Optimising diagnosis and post-diagnostic support for people living with dementia: geriatricians' views.

Authors:  Elise Mansfield; Jamie Bryant; Balakrishnan R Nair; Alison Zucca; Ranjeev Chrysanth Pulle; Rob Sanson-Fisher
Journal:  BMC Geriatr       Date:  2022-02-19       Impact factor: 3.921

5.  Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent.

Authors:  K Ribi; N Kalbermatten; M Eicher; F Strasser
Journal:  ESMO Open       Date:  2022-05-18

6.  Support persons' preferences for the type of consultation and the format of information provided when making a cancer treatment decision.

Authors:  Anne Herrmann; Rob Sanson-Fisher; Alix Hall; Laura Wall; Nicholas Zdenkowski; Amy Waller
Journal:  BMC Res Notes       Date:  2018-07-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.